# n-3 PUFA for Vascular Cognitive Aging

> **NCT01953705** · PHASE2 · UNKNOWN · sponsor: **Oregon Health and Science University** · enrollment: 102 (actual)

## Conditions studied

- Age Related Cognitive Decline
- Alzheimer's Disease
- Vascular Dementia
- Endothelial Dysfunction
- Executive Dysfunction

## Interventions

- **DRUG:** Omega 3 PUFA
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01953705
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-05
- **Primary completion:** 2020-12
- **Final completion:** 2021-06
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2020-09-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01953705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01953705, "n-3 PUFA for Vascular Cognitive Aging". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01953705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*